Tegricel Colostrum
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- Limited research evidence available for ingredients
B
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
1 Capsule(s)
Serving Size
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Supplement Facts — Evidence Check
575 mg
📊 Market median: 800.0mg (172 products)
Other Ingredients
Microcrystalline Cellulose
Silicon Dioxide
soy lecithin
Label Claims — Verification
❓
All Other
All Other (99% of products)
Structure/Function (84% of products)
Nutrient (26% of products)
No Claim (1% of products)
Target Groups
Adult (18 - 50 Years)
Gluten Free
Product Information
📋 Directions for Use
Recommended Use: As a dietary supplement, take one capsule daily, or as directed by your health care practitioner.
⚠️ Warnings & Precautions
Contains: Milk.
KEEP OUT OF REACH OF CHILDREN.
🧪 Formulation Notes
Does not contain gluten.
Additional Information
Notice: Color, size or shape may appear different between lots.
TEG090
For Professional Use Only
Manufactured in a GMP CERTIFIED Facility
STORE IN A COOL, DRY PLACE.
Product Details
UPC / SKU
8 79452 00100 8
DSLD Entry Date
2013-07-25
Product Type
Non-Nutrient/Non-Botanical
Form
Capsule
Brand
Designs for Health
DSLD ID
22539
Data Updated
2026-04-11
Research Evidence
19
Research Sources
52
Avg Quality Score
8
Clinical Trial
4
Cochrane Review
2
Systematic Review
2
Meta Analysis
2
Guideline
1
Rct
B
[Expert consensus on the application of intravenous immunoglobulin in children with autoimmune neurological disorders (2025)].
B
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).
B
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barré syndrome.
B
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
B
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
B
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
C
Intravenous immunoglobulin for myasthenia gravis
C
Impact of Selenium Supplementation in Neutropenia and Immunoglobulin Production in Childhood Cancer Patients
C
Breast-Milk Iodine Concentrations and Iodine Levels of Infants According to the Iodine Status of the Country of Residence: A Systematic Review and Meta-Analysis
Compare Similar Products
Mother's Gift Colostrum
Roex
100
Amyloid Benefits
DaVinci Benefits Line
100
Amyloid Complete
DaVinci Laboratories
100
Colostrum ImmunDefense
Wonder Laboratories
100
GALT-immune
Energetix
100